- Home
- ALDX vs EUDA Comparison
ALDX vs EUDA Comparison
Compare ALDX & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- EUDA
- Stock Information
- Founded
- ALDX 2004
- EUDA 2021
- Country
- ALDX United States
- EUDA Singapore
- Employees
- ALDX N/A
- EUDA N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- EUDA Blank Checks
- Sector
- ALDX Health Care
- EUDA Finance
- Exchange
- ALDX Nasdaq
- EUDA Nasdaq
- Market Cap
- ALDX 133.7M
- EUDA 152.3M
- IPO Year
- ALDX 2014
- EUDA N/A
- Fundamental
- Price
- ALDX $2.24
- EUDA $3.95
- Analyst Decision
- ALDX Strong Buy
- EUDA
- Analyst Count
- ALDX 2
- EUDA 0
- Target Price
- ALDX $9.50
- EUDA N/A
- AVG Volume (30 Days)
- ALDX 1.5M
- EUDA 105.8K
- Earning Date
- ALDX 05-20-2025
- EUDA 01-01-0001
- Dividend Yield
- ALDX N/A
- EUDA N/A
- EPS Growth
- ALDX N/A
- EUDA N/A
- EPS
- ALDX N/A
- EUDA N/A
- Revenue
- ALDX N/A
- EUDA $4,011,005.00
- Revenue This Year
- ALDX N/A
- EUDA $212.19
- Revenue Next Year
- ALDX N/A
- EUDA $254.35
- P/E Ratio
- ALDX N/A
- EUDA N/A
- Revenue Growth
- ALDX N/A
- EUDA 8.22
- 52 Week Low
- ALDX $1.14
- EUDA $1.85
- 52 Week High
- ALDX $7.20
- EUDA $6.30
- Technical
- Relative Strength Index (RSI)
- ALDX 36.53
- EUDA 54.56
- Support Level
- ALDX $1.90
- EUDA $3.66
- Resistance Level
- ALDX $2.89
- EUDA $3.97
- Average True Range (ATR)
- ALDX 0.22
- EUDA 0.17
- MACD
- ALDX 0.09
- EUDA 0.00
- Stochastic Oscillator
- ALDX 33.46
- EUDA 53.57
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.